Pain, Chronic, Pain, Joint, Pain Syndrome
Conditions
Brief summary
purpose of this study is to evaluate the level of pain perceived by patients using a transdermal cream and/or transdermal patch with or without an oral medication as a pain management solution.
Detailed description
The purpose of this minimal risk, observational study is to observe and document patients' perspective on how the combination of transdermal cream and/or transdermal patch(s) with or without oral medication can help reduce or eliminate the use of opiate(s).
Interventions
transdermal cream and/or transdermal patch(s) with or without oral medication
Sponsors
Study design
Eligibility
Inclusion criteria
* Participants must be diagnosed with an ICD10 code indicative of chronic pain * Participants must be starting a new regimen of topical therapy with or without non-narcotic oral medication that has been deemed medically necessary and is independent of the study * Participants must be expecting to receive therapy for at least 12 weeks * Participants must be between 18 and 64 years of age * Participants must be able to provide sound verbal informed consent
Exclusion criteria
* Participants must not be a beneficiary of government funded healthcare program (i.e. Medicare, Medicaid, etc.) * Participants must not have a diagnosis of cancer within the past 5 years * Participants who have chronic pain conditions not expected to respond to topical pain medication such as deep abdominal pain, or from conditions such as cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patients' perspective through a patient led Survey of Health and quality of life via patient reported outcome measures using Visual analogue scale given at Baseline and follow up. Measuring pain from 0 no pain to 10 highest pain level. | 36 months | Collecting and analyzing quantitative and qualitative data to draw generalized outcome measures, on real world data.Data from the subject surveys will analyze and measure the effectiveness through a subjective observation via patients' perspective survey on transdermal cream and/or transdermal patches with or without oral non-narcotic medication and if it helped with the reduction or elimination of opiate(s). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analogue scales | 36 months | By utilizing the Visual analogue scale from the patients' perspective will generate real world data |
Countries
United States